ArticleFrontiers in neurology2025
Lipocalin-2 in preoperative cerebrospinal fluid is a biomarker for postoperative delirium after hip fracture surgery in older adults: a prospective cohort study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative delirium (POD) is a common central nervous system complication in older adult surgical patients. At present, the mechanism for POD is still unclear. Lipocalin-2 (LCN2) may have an impact on cognitive function, but the relationship between LCN2 and POD has remained unclear. Therefore, we sought to investigate the relationship between the levels of LCN2 in plasma and cerebrospinal fluid (CSF) and the occurrence of POD in older adults undergoing hip fracture surgery. Methods: We conducted a prospective observational cohort study involving 186 older adults (≥65 years old) who underwent hip fracture surgery under spinal anesthesia. CSF and blood samples were collected. The levels of LCN2, interleukin-6 (IL-6), and interleukin-1 (IL-1) were measured using an enzyme-linked immunosorbent assay (ELISA). We used the 3-min diagnostic interview to evaluate delirium defined by the Confusion Assessment Method (3D-CAM), to screen for POD, and the Memorial Delirium Assessment Scale (MDAS) to evaluate the severity of delirium. Multivariable logistic regression was applied to identify independent predictive factors for POD. The relationship between CSF LCN2 levels and POD risk was assessed through receiver operating characteristic (ROC) curve analysis. Correlation analysis was used to investigate the association between CSF LCN2 and MDAS scores as well as IL-6. Results: Among the 186 patients ultimately included, 29 (15.6%) developed POD. Their preoperative CSF LCN2 level was significantly higher than that of those without POD ( Conclusion: Elevated preoperative CSF LCN2 levels are associated with an increased risk and severity of POD in older adults undergoing hip fracture surgery. Clinical trial registration: https://www.chictr.org.cn/, ChiCTR2200061407.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.